Our studies on tissues from patients with benign and malignant thyroid lesions showed a significant contribution of the BRAF V600E mutation and changes in the expression of RASSF1A, DIRAS3, and AKAP9 genes in developing this type of cancer. This evidence concerns the gene AKAP9 and cancer.